Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
4.360
+0.030 (0.69%)
At close: Jun 18, 2026, 4:00 PM EDT
4.280
-0.080 (-1.83%)
After-hours: Jun 18, 2026, 4:56 PM EDT
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $348.92 million as of June 18, 2026. Its market cap has increased by 26.23% in one year.
Market Cap
348.92M
Enterprise Value
93.55M
1-Year Change
26.23%
Ranking
Category
Stock Price
$4.36
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $348.92M, a decrease of -81.99%. That is a compound annual growth rate of -26.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 348.92M | 25.10% |
| Dec 31, 2025 | 278.91M | -1.43% |
| Dec 31, 2024 | 282.95M | 11.19% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuvectis Pharma | 366.58M |
| Rocket Pharmaceuticals | 365.80M |
| Compass Therapeutics | 363.78M |
| Verastem | 362.04M |
| Zura Bio | 356.24M |
| Vanda Pharmaceuticals | 348.79M |
| Greenwich LifeSciences | 343.18M |
| Upstream Bio | 340.12M |